138 related articles for article (PubMed ID: 3362877)
1. Management of advanced cancer of prostate and bladder. Proceedings of a symposium on the tenth anniversary of EORTC, Leeds, England, October 3rd, 1986 and the Fifth Course in Urological Oncology, Erice, Sicily, November 28-December 4th, 1986.
Prog Clin Biol Res; 1988; 260():1-658. PubMed ID: 3362877
[No Abstract] [Full Text] [Related]
2. [The urological group of the EORTC (European Organization for Research on the Treatment of Cancer), 1976-1984].
Smith PH; de Pauw M; Sylvester R
Arch Esp Urol; 1984 Dec; 37 Suppl 2():713-23. PubMed ID: 6543605
[No Abstract] [Full Text] [Related]
3. [Clinical analysis of double cancer involving bladder and prostate].
Yumura Y; Oogo Y; Takase K; Kato Y; Hamano A; Noguchi S; Fukuda M; Satomi Y
Hinyokika Kiyo; 2006 Apr; 52(4):255-8. PubMed ID: 16686351
[TBL] [Abstract][Full Text] [Related]
4. End-results in cancer of the prostate and the urinary bladder, 1940 to 1959.
Eisenberg H; Heise H
Proc Natl Cancer Conf; 1964; 5():331-40. PubMed ID: 5856164
[No Abstract] [Full Text] [Related]
5. Urological cancer guidelines: are there any differences?
Meyer JP; Sullivan ME; Bell RC
BJU Int; 2006 Nov; 98(5):940-1. PubMed ID: 17034592
[No Abstract] [Full Text] [Related]
6. Pediatric urologic oncology: bladder, prostate, testis.
Wu HY; Snyder HM
Urol Clin North Am; 2004 Aug; 31(3):619-27, xi. PubMed ID: 15313070
[TBL] [Abstract][Full Text] [Related]
7. [Management of bladder cancer associated with prostate cancer].
Bonnal JL; Irani J; Maidenberg M; Théodore C; Mauroy B
Prog Urol; 2003 Dec; 13(6):1286-9. PubMed ID: 15000300
[TBL] [Abstract][Full Text] [Related]
8. The immunotherapy of prostate and bladder cancer.
Totterman TH; Loskog A; Essand M
BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
[TBL] [Abstract][Full Text] [Related]
9. [Cancer of the urinary bladder and prostatic gland in Kalmykia].
Nidiulin VA
Urologiia; 2006; (3):36-8. PubMed ID: 16889088
[TBL] [Abstract][Full Text] [Related]
10. EORTC Genitourinary Group Monograph 2, Part B. Superficial bladder tumors. Proceedings of a symposium held in York, England, November 16 and 17, 1984.
Prog Clin Biol Res; 1985; 185B():1-179. PubMed ID: 4034584
[No Abstract] [Full Text] [Related]
11. Is there an optimal comorbidity index for prostate cancer?
Cai T; Bartoletti R
Cancer; 2008 Sep; 113(5):1109; author reply 1109-10. PubMed ID: 18543325
[No Abstract] [Full Text] [Related]
12. Bladder/prostate rhabdomyosarcoma: miles to go before we sleep.
Womer RB; Snyder HM
J Urol; 2006 Oct; 176(4 Pt 1):1278-9. PubMed ID: 16952611
[No Abstract] [Full Text] [Related]
13. The application of epigenetic modifiers on the treatment of prostate and bladder cancer.
Zhang Z; Karam J; Frenkel E; Sagalowsky A; Hsieh JT
Urol Oncol; 2006; 24(2):152-60. PubMed ID: 16520279
[TBL] [Abstract][Full Text] [Related]
14. Open clinical uro-oncology trials in Canada.
Mackenzie MJ; Rodrigues G; Winquist E
Can J Urol; 2009 Jun; 16(3):4706-11. PubMed ID: 19497189
[No Abstract] [Full Text] [Related]
15. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
Helpap B; Klöppel G
Virchows Arch; 2002 Mar; 440(3):241-8. PubMed ID: 11889593
[TBL] [Abstract][Full Text] [Related]
16. Urologic cancer. Urologic Oncology Workgroup, Legislative Task Force on Cancer in Texas.
Swanson DA; Anthony WA; Avant OL; Curtis WP; Ferrell JM; Keegan GT; McMillin TR; Peters PC; Sarosdy M; Warren MM
Tex Med; 1987 Sep; 83(9 Pt 2):17-23. PubMed ID: 3672402
[No Abstract] [Full Text] [Related]
17. Open clinical uro-oncology trials in Canada.
Mackenzie M; Rodrigues G; Winquist E
Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
[No Abstract] [Full Text] [Related]
18. Carcinoma of the bladder, prostate and testicle.
Garland JB
Practitioner; 1984 Aug; 228(1394):725-9. PubMed ID: 6473276
[No Abstract] [Full Text] [Related]
19. Open clinical uro-oncology trials in Canada.
Rodrigues G; Winquist E
Can J Urol; 2010 Dec; 17(6):5494-9. PubMed ID: 21172119
[No Abstract] [Full Text] [Related]
20. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
